|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2021
12 months to Jun 30, 2021
|
FY2020
12 months to Jun 30, 2020
|
FY2019
12 months to Jun 30, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss): | |||||
| Mark-to-market adjustments | |||||
| Net change due to non-cash issuance of stock | |||||
| Fund in transit | |||||
| Acc. Other Comprehensive Inc (Loss) | |||||
| Reserve for loan penalties | |||||
| Adjustments to reconcile net income to net cash used in operating activities: | |||||
| (Increase) decrease in assets and prepaid expenses | |||||
| Marketable securities | |||||
| Total deferred financing costs | |||||
| Total (increase) decrease in assets and prepaid expenses | |||||
| Increase (decrease) in accounts payable and accrued expenses | |||||
| Accounts payable | |||||
| Sub-fund obligations | |||||
| Accrued expenses | |||||
| Advances from customers and client deposits | |||||
| Derivative liabilities | |||||
| Total increase (decrease) in accounts payable and accrued expenses | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Loans from Directors/Officers | |||||
| Net Loans from Directors/Officers | |||||
| Notes payable (net) | |||||
| Common Stock (including stock to be issued) | |||||
| Net cash provided by (used in) financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
Loading...